AbClon Inc. (KOSDAQ:174900)
South Korea · Delayed Price · Currency is KRW 23,700
-900 (-3.66%)
Sep 1, 2026, 3:30 PM KST
AbClon Market Cap
AbClon has a market cap or net worth of 490.82 billion as of September 1, 2026. Its market cap has increased by 154.02% in one year.
Market Cap
490.82B
Enterprise Value
462.18B
Revenue
5.31B
Ranking
n/a
PE Ratio
n/a
Stock Price
23,700.00
ChartMarket Cap Chart
Since September 18, 2017, AbClon's market cap has increased from 176.80B to 490.82B, an increase of 177.61%. That is a compound annual growth rate of 12.08%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 31, 2026 | 490.82B | -39.57% |
| Dec 30, 2025 | 812.27B | 230.14% |
| Dec 30, 2024 | 246.04B | 6.90% |
| Dec 28, 2023 | 230.16B | 17.39% |
| Dec 29, 2022 | 196.07B | -27.49% |
| Dec 30, 2021 | 270.42B | -48.52% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Sep 18, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Chabiotech | 754.82B |
| Pharmicell | 673.25B |
| Onconic Therapeutics | 670.67B |
| Komipharm International | 669.89B |
| Hyundai Bioscience | 631.13B |
| GI Innovation | 521.93B |
| Medy-Tox | 463.40B |
| GC Corp. | 460.37B |